Close Menu

NEW YORK (GenomeWeb) – Great Basin Scientific announced today that it will no longer pursue a previously announced plan to raise $8 million in equity financing.

The firm has asked the US Securities and Exchange Commission to withdraw its S-1 registration statement connected to the planned financing, as a result. 

Great Basin had intended to raise additional funds when it entered into a convertible note financing last July, saying it anticipated needing the additional funds to finance operations in late 2016 through early 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.